A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
Public ClinicalTrials.gov record NCT06721156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia
Study identification
- NCT ID
- NCT06721156
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- MK-1167 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2024
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2026
- Last update posted
- Mar 15, 2026
2024 – 2026
United States locations
- U.S. sites
- 28
- U.S. states
- 12
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute ( Site 0110) | Phoenix | Arizona | 85006 | — |
| Irvine Clinical Research ( Site 0104) | Irvine | California | 92614 | — |
| Anderson Clinical Research ( Site 0164) | Redlands | California | 92374 | — |
| California Neuroscience Research ( Site 0118) | Sherman Oaks | California | 91403 | — |
| JEM Research Institute / Headlands Research Network ( Site 0108) | Atlantis | Florida | 33462 | — |
| Brain Matters Research-Neurology ( Site 0150) | Delray Beach | Florida | 33445 | — |
| Neuropsychiatric Research Center of Southwest Florida ( Site 0152) | Fort Myers | Florida | 33912 | — |
| Indago Research & Health Center, Inc ( Site 0128) | Hialeah | Florida | 33012 | — |
| K2 Medical Research THE VILLAGES ( Site 0166) | Lady Lake | Florida | 32159 | — |
| K2 Medical Research ( Site 0103) | Maitland | Florida | 32750 | — |
| Premier Clinical Research Institute ( Site 0114) | Miami | Florida | 33122 | — |
| Aqualane Clinical Research ( Site 0116) | Naples | Florida | 34105 | — |
| Headlands Research Orlando ( Site 0169) | Orlando | Florida | 32806 | — |
| Brain Matters Research ( Site 0151) | Stuart | Florida | 34997 | — |
| K2 Medical Research ( Site 0165) | Tampa | Florida | 33634 | — |
| Columbus Memory Center ( Site 0197) | Columbus | Georgia | 31909 | — |
| CenExel iResearch, LLC ( Site 0134) | Savannah | Georgia | 31405 | — |
| Tandem Clinical Research ( Site 0101) | Marrero | Louisiana | 70072 | — |
| Pharmasite Research, Inc. ( Site 0167) | Baltimore | Maryland | 21208 | — |
| Quest Research Institute ( Site 0173) | Farmington Hills | Michigan | 48334 | — |
| Velocity Clinical Research, Syracuse ( Site 0125) | East Syracuse | New York | 13057 | — |
| Mid Hudson Medical Research ( Site 0191) | New Windsor | New York | 12553 | — |
| Flourish Research - Charlotte ( Site 0106) | Matthews | North Carolina | 28105 | — |
| Velocity Clinical Research - Raleigh ( Site 0123) | Raleigh | North Carolina | 27607 | — |
| Summit Research Network ( Site 0111) | Portland | Oregon | 97210 | — |
| Kerwin Medical Center ( Site 0159) | Dallas | Texas | 75231 | — |
| Grayline Research Center ( Site 0105) | Wichita Falls | Texas | 76309 | — |
| Northwest Clinical Research Center ( Site 0102) | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06721156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2026 · Synced Apr 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06721156 live on ClinicalTrials.gov.